Each 5 ml Contains: IP

• Displays dual modes of action to counter allergic manifestations

• Montelukast: Inhibits leukotrienes & produces anti-inflammatory and brochodilating effects
• Levocetirizine: Inhibits histamine action at H1 receptors and reduces allergic manifestations

• Considered as a more effective strategy in allergic rhinitis Combination therapy (Montelukast + Levocetirizine) is a more effective strategy than monotherapy in the treatment of persistent allergic rhinitis."
• Improves quality of life of affected patient